Valuation | Industry Range | |
---|---|---|
Price / Earnings | N/A | |
Book Value | 4.16 |   |
Earnings Per Share | -$1.96 |   |
Price To Sales Ratio | 27.29 |   |
Price To Book Ratio | 4.00 |   |
Price To Tangible Book Ratio | 4.06 |   |
Price/Cash Flow Ratio | N/A | |
Price/Free Cash Flow Ratio | N/A |
Profile | Industry Range | |
---|---|---|
Market Capitalization | 338.5M |   |
Float (MRQ) | 78.56% |   |
Shares Outstanding (MRQ) | 44.5M |   |
Short Interest as a % of Float (MRQ) | 6.52% |   |
Shares Held By Institutions (MRQ) | 22.5M |   |
Margins | Industry Range | |
---|---|---|
Sales | $38.7M |   |
Gross Margin | 89.21% |   |
Net Profit Margin | -224.55% |   |
EBIT Margin | -206.23% |   |
EBITDA Margin | -184.98% |   |
Operating Margins | -206.23% |   |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
Financial Strength | Industry Range | |
---|---|---|
Current Ratio (MRQ) | 2.69 |   |
Quick Ratio (MRQ) | 2.69 |   |
Total Debt/Equity Ratio (MRQ) | 15.13 |   |
Debt/Common Equity Ratio (MRQ) | 15.13 |   |
Effectiveness | Industry Range | |
---|---|---|
Return on Equity | -47.00% |   |
Return on Assets | -49.00% |   |
Asset Turnover | 0.22 |   |
Receivables Turnover | 2.21 |   |
Inventory Turnover | N/A |
Earnings and Dividends | Industry Range | |
---|---|---|
EPS Growth Annual | 19.39% |   |
Dividend Yield 5 Year Average | 0.00% |   |
Current Dividend Yield | 0.00% |   |
Current Payout Ratio | N/A |
*MGTX does not pay a dividend. The average dividend yield for companies in the Biotechnology industry is 1.49%